PROJECT

Projects

Summary of Investment Information

Project Number

41947

Company Name

JOINTOWN PHARMACEUTICAL GROUP CO., LTD.

Date SPI Disclosed

Mar 20, 2019

Country

China

Region

East Asia and the Pacific

Projected Board Date

May 15, 2019

Environmental Category

B - Limited

Status

Active

Last Updated Date

Jul 13, 2019

Department

Regional Industry - MAS Asia & Pac

Industry

Health, Education and Life Sciences

Previous Events

Approved : May 29, 2019
Signed : May 30, 2019
Invested : Jul 10, 2019

Sector

other

Project Description

 Jointown Pharmaceutical Group Co., Ltd. (“Jointown” or the “Company”) is a major pharmaceutical product distribution company founded in 1999 in China with its headquarter based in Wuhan province and is publicly listed on the Stock Exchange of Shanghai (600998 SHA), with 31 provincial level and 94 prefecture level product distribution and logistics centers throughout China. The Company procures pharmaceutical products and small medical devices, stores in its large network of logistical centers in China, to be subsequently sold to hospitals, clinics, and pharmacies throughout China, transported through its own 1700-strong truck fleet, and via 85 third-party truck fleet companies throughout China contracted by the company on an as-needed basis. IFC is looking to support Jointown’s expansion, which comprises of the construction of up to 5 new product distribution centers and upgrading of 4 existing warehouses in Middle and Western China (the “Project”).                                                 

Associated Advisory Engagement

IFC is helping the Company in designing the Project facilities in compliance with the IFC green building standards.                                                   

Sponsor / Cost / Location

Development Impact

E&S Category Rationale / Risks and Mitigation